Patents by Inventor Raul CHERTKOFF

Raul CHERTKOFF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC REGIMEN FOR THE TREATMENT OF FABRY USING STABILIZED ALPHA-GALACTOSIDASE
    Publication number: 20200155654
    Abstract: Methods of treating Fabry disease via administration of stabilized plant recombinant human alpha galactosidase protein comprising at least two alpha-galactosidase monomers being covalently linked to one another via a linking moiety, and unit dosages of protein are disclosed herein. The disclosed protocols are safe, have greater than 2 week intervals between administrations and exhibit important improvement in patient's disease parameters, in terms of reduced Gb3 accumulation, pain and GI parameters, kidney and cardiac stabilization in the clinical setting.
    Type: Application
    Filed: January 5, 2018
    Publication date: May 21, 2020
    Applicant: Protalix Ltd.
    Inventors: Einat ALMON, Raul CHERTKOFF, Sari ALON, Yoseph SHAALTIEL